Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2311-2313

  Goldfrank, Deborah ^a   Chuai, Shannon ^a   Bernstein, Jonine L ^a   Ramon Y Cajal, Teresa ^b   Lee, Johanna B ^a   Alonso, M Carmen ^b   Diez, Orland ^b   Baiget, Monserrat ^b   Kauff, Noah D ^a   Offit, Kenneth ^a   Robson, Mark ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HOSPITAL SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOTE; HUMAN; IN VITRO STUDY; IONIZING RADIATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIOSENSITIVITY;

ADULT; AGED; EARLY DIAGNOSIS; FEMALE; GENES, BRCA1; GENES, BRCA2; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MUTATION; ODDS RATIO; OUTCOME ASSESSMENT (HEALTH CARE); QUESTIONNAIRES; RISK;

EID: 33845310037     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0176     Document Type: Article

References (15)

1. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
2. Burke W, Daly M, Garber J, et al. Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. JAMA 1997;277:997-1003.
3. National Comprehensive Cancer Centers. Clinical practice guidelines in oncology: genetic/familial high-risk assessment: breast and ovarian, version 1.2006. Jenkintown (PA): National Comprehensive Cancer Centers; 2005 [accessed 2005 Dec 20].
4. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD, Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002;158:220-35.
5. Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity, and the cellular response to ionizing radiation. Oncogene 2003;22:5784-91.
6. Buchholz TA, Wu X, Hussain A, et al. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2. Int J Cancer 2002;97:557-61.
7. Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J. γ-Rays-induced death of human cells carrying mutations of BRCAl or BRCA2. Oncogene 1999;18:7334-42.
8. 1/S cell cycle checkpoint following UVA irradiation but show normal levels of micronuclei following oxidative srress or mitomycin C treatment. Int J Radiat Oncol Biol Phys 2004;58:470-8.
9. Baeyens A, Thierens H, Claes K, Poppe B, de RL, Vral A. Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriers. Int J Radiat Biol 2004;80:745-56.
10. Nieuwenhuis B, Van Assen-Bolt AJ, Van Waarde-Verhagen MA, et al. BRCA1 and BRCA2 heterozygosity and repair of X-ray-induced DNA damage. Int J Radiat Biol 2002;78:285-95.
11. Trenz K, Schutz P, Speit G. Radiosensitivity of lymphoblastoid cell lines with a heterozygous BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis. Mutagenesis 2005;20: 131-7.
12. Andrieu N, Easton D, Chang-Claude J, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study. J Clin Oncol 2006;24:3361-6.
13. Narod SA, Lubinski J, Ghadirian P, et al. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Lancet Oncol 2006; 7:402-6.
14. Kriege M, Brekelmans CT, Boetes C, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-37.
15. Leach MO, Boggis CR, Dixon AK, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365:1769-78.